Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma.

Current therapeutic approaches to asthma have had limited impact on the clinical management and resolution of this disorder. By using a novel vaccine strategy targeting the inflammatory cytokine IL-5, we have ameliorated hallmark features of asthma in mouse models. Delivery of a DNA vaccine encoding murine IL-5 modified to contain a promiscuous foreign Th epitope bypasses B cell tolerance to IL-5 and induces neutralizing polyclonal anti-IL-5 Abs. Active vaccination against IL-5 reduces airways inflammation and prevents the development of eosinophilia, both hallmark features of asthma in animal models and humans. The reduced numbers of inflammatory T cells and eosinophils in the lung also result in a marked reduction of Th2 cytokine levels. Th-modified IL-5 DNA vaccination reduces the expression of IL-5 and IL-4 by approximately 50% in the airways of allergen-challenged mice. Most importantly, Th-modified IL-5 DNA vaccination restores normal bronchial hyperresponsiveness to beta-methacholine. Active vaccination against IL-5 reduces key pathological events associated with asthma, such as Th2 cytokine production, airways inflammation, and hyperresponsiveness, and thus represents a novel therapeutic approach for the treatment of asthma and other allergic conditions.
AuthorsM Hertz, S Mahalingam, I Dalum, S Klysner, J Mattes, A Neisig, S Mouritsen, P S Foster, A Gautam
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 167 Issue 7 Pg. 3792-9 (Oct 1 2001) ISSN: 0022-1767 [Print] United States
PMID11564796 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Immunoglobulins
  • Interleukin-5
  • Vaccines, DNA
  • Ovalbumin
  • Animals
  • Asthma (immunology, therapy)
  • B-Lymphocytes (immunology)
  • Bronchial Hyperreactivity (therapy)
  • Cells, Cultured
  • Cytokines (biosynthesis)
  • Immunoglobulins (biosynthesis)
  • Inflammation (therapy)
  • Interleukin-5 (genetics, immunology)
  • Mice
  • Mice, Inbred C3H
  • Ovalbumin (immunology)
  • Pulmonary Eosinophilia (therapy)
  • Self Tolerance
  • Th2 Cells (immunology)
  • Vaccines, DNA (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: